WHO reported outbreak of western equine encephalitis in Argentina
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced study results that showed…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of…
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
On Dec. 20, 2023, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratory (NVSL) announced it…
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
On Dec. 19, 2023, the U.S. Food and Drug Administration approved the first test that uses DNA in…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
On Dec. 15, 2023, In a pivotal move towards addressing one of the worldメs most underrecognized health challenges,…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Dec. 14, 2023, the Department of Energy’s Pacific Northwest National Laboratory announced that it had created the…
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
On Dec. 7, 2023, the U.S. Food and Drug Administration reported that of the more than 116 medically…